- Home
- CRNX vs NZF Comparison
CRNX vs NZF Comparison
Compare CRNX & NZF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- NZF
- Stock Information
- Founded
- CRNX 2008
- NZF 2001
- Country
- CRNX United States
- NZF United States
- Employees
- CRNX N/A
- NZF N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- NZF Finance Companies
- Sector
- CRNX Health Care
- NZF Finance
- Exchange
- CRNX Nasdaq
- NZF Nasdaq
- Market Cap
- CRNX 2.8B
- NZF 2.3B
- IPO Year
- CRNX 2018
- NZF N/A
- Fundamental
- Price
- CRNX $30.40
- NZF $11.91
- Analyst Decision
- CRNX Strong Buy
- NZF
- Analyst Count
- CRNX 7
- NZF 0
- Target Price
- CRNX $74.33
- NZF N/A
- AVG Volume (30 Days)
- CRNX 1.0M
- NZF 496.8K
- Earning Date
- CRNX 08-07-2025
- NZF 01-01-0001
- Dividend Yield
- CRNX N/A
- NZF 4.67%
- EPS Growth
- CRNX N/A
- NZF N/A
- EPS
- CRNX N/A
- NZF N/A
- Revenue
- CRNX $1,392,000.00
- NZF N/A
- Revenue This Year
- CRNX $489.51
- NZF N/A
- Revenue Next Year
- CRNX $661.93
- NZF N/A
- P/E Ratio
- CRNX N/A
- NZF N/A
- Revenue Growth
- CRNX 0.51
- NZF N/A
- 52 Week Low
- CRNX $24.10
- NZF $9.82
- 52 Week High
- CRNX $62.53
- NZF $12.29
- Technical
- Relative Strength Index (RSI)
- CRNX 53.04
- NZF 54.56
- Support Level
- CRNX $28.73
- NZF $11.87
- Resistance Level
- CRNX $31.70
- NZF $12.03
- Average True Range (ATR)
- CRNX 1.29
- NZF 0.07
- MACD
- CRNX 0.25
- NZF 0.00
- Stochastic Oscillator
- CRNX 77.85
- NZF 62.50
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About NZF Nuveen Municipal Credit Income Fund
Nuveen Municipal Credit Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and to enhance portfolio value relative to the municipal bond market by investing in an actively managed portfolio of tax-exempt municipal securities.